Oct.29.2021
R & D
Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic Pancreatic Cancer and Interim Analysis of Pivotal Phase 3 Clinical Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia
This information is intended to notify the press release issued on October 28 (local time) by Rafael Pharmaceuticals, Inc.
Please click https://rafaelpharma.com/press-releases for the original press release.